A Preliminary Study on the Relationship between Serum Heparan Sulfate and Cancer-Related Cognitive Impairment: The Moderating Role of Oxidative Stress in Patients with Colorectal Cancer
Open Access
- 12 April 2022
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 29 (4) , 2681-2694
Abstract
Cancer-related cognitive impairment (CRCI) has been frequently reported in colorectal cancer survivors. Heparan sulfate (HS) was gradually considered to be related to cognitive disorders. The effect and potential mechanism of HS on CRCI in colorectal cancer patients were unexplored. In this study, all participants were divided into a cognitive impaired group and a cognitive normal group. The concentrations of oxidative stress factors and HS in serum were detected. Associations among HS, oxidative stress factors and CRCI were evaluated. Participants with cognitive impairment exhibited increased levels of HS, GSH, SOD and MDA, compared to the patients with normal cognitive performance. The independent significant association was found between HS and CRCI after controlling for various covariates. The higher concentrations of HS were related to the decreased cognitive performance among survivors who reported higher levels of GSH (β = 0.080, p = 0.002). Moreover, the nonlinear association between the level of HS and cognitive scores was confirmed using the restricted cubic splines (p < 0.001). These results indicated that the increased concentrations of circulating HS had a nonlinear negative connection with cognitive performance in colorectal cancer survivors, which was moderated by GSH. HS might be a new biomolecule for the identification and management of patients with CRCI.Keywords
Funding Information
- National Natural Science Foundation of China (82172583)
- Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (BJ 2020041)
This publication has 52 references indexed in Scilit:
- Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled StudyJournal of Clinical Oncology, 2015
- Cognitive function and fatigue after diagnosis of colorectal cancerAnnals of Oncology, 2014
- Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patientsJournal of Clinical Epidemiology, 2014
- Heparan sulfate in the nucleus and its control of cellular functionsMatrix Biology, 2014
- Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast CancerValue in Health, 2013
- Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Brain, Behavior, and Immunity, 2013
- Glia and epilepsy: excitability and inflammationTrends in Neurosciences, 2013
- French version of the Functional Assessment of Cancer Therapy–Cognitive Function (FACT-Cog) version 3Supportive Care in Cancer, 2012
- How does multiple testing correction work?Nature Biotechnology, 2009
- Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with Hematopoetic Stem Cell Transplant PatientsJournal of Pain and Symptom Management, 2007